(Reuters) -Laboratory operator Labcorp beat Wall Street estimates for third-quarter profit and revenue on Thursday as strong demand for diagnostic tests offset a hit from hurricane-led disruptions.
Hosted on MSN
Q2 Earnings Outperformers: Labcorp (NYSE:LH) And The Rest Of The Testing & Diagnostics Services Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Labcorp (NYSE:LH) and the rest ...
Restructuring and other charges represent amounts incurred in connection with the elimination of redundant positions and facilities and contract termination costs within the organization in connection ...
Labcorp will start testing for monkeypox, doubling testing capacity nationwide. Labcorp will start testing for monkeypox, doubling testing capacity nationwide. Beginning Wednesday, Labcorp will test ...
LabCorp LH delivered third-quarter results that closely track with our full-year topline expectations. Gross margin year-to-date has run slightly behind our projections, but that was partially offset ...
Today, Visby Medical announced two new relationships that will expand national access to the Visby Women’s Sexual Health Test ...
As syphilis cases surge nationwide, the collaboration will bring the First To Know ® over-the-counter test to clinicians and patients across professional and hospital settings SPRINGDALE, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results